Crossmark

Candidate probiotic Lactiplantibacillus plantarum HNU082 rapidly and convergently evolves within human, mice, and zebrafish gut but differentially influences the resident microbiome

Crossref DOI link: https://doi.org/10.1186/s40168-021-01102-0

Published Online: 2021-06-30

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Huang, Shi

Jiang, Shuaiming

Huo, Dongxue

Allaband, Celeste

Estaki, Mehrbod

Cantu, Victor

Belda-Ferre, Pedro

Vázquez-Baeza, Yoshiki

Zhu, Qiyun

Ma, Chenchen

Li, Congfa

Zarrinpar, Amir

Liu, Yang-Yu

Knight, Rob

Zhang, Jiachao https://orcid.org/0000-0001-8099-6749
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (31701577)

National Institutes of Health (T32 OD017863, K08 DK102902, R01AI141529, R01HD093761, R01AG067744)

NIDDK (P30 DK120515, P30 DK063491, and UL1 TR001442)

National Center for Complementary and Integrative Health (DP1-AT010885)
License Information

Text and Data Mining valid from 2021-06-30

Version of Record valid from 2021-06-30
More Information

Article History

Received: 7 January 2021

Accepted: 24 May 2021

First Online: 30 June 2021

Declarations

:

: The study was reviewed and approved by the Ethics Committee of Hainan University (HNU-2018037, Haikou, China), and informed consent was obtained from all volunteers before they enrolled in the study. The participants provided written informed consent to participate in the study. Sampling and all described subsequent steps were conducted in accordance with the approved guidelines.

: Not applicable.

: AZ is a founder and equity-holder in Tortuga Biosciences.

Document is current

Any future updates will be listed below